Valuation : EBOS Group Limited

Market Cap 3.37B 2.42B 2.08B 1.97B 1.79B 3.35B 231B 23.41B 9B 117B 9.07B 8.87B 371B P/E 2027 *
14.4x
P/E 2028 * 12.7x
Enterprise Value 4.38B 3.14B 2.71B 2.56B 2.32B 4.36B 300B 30.45B 11.71B 153B 11.8B 11.54B 483B EV / Sales 2027 *
0.31x
EV / Sales 2028 * 0.3x
Free-Float
89.8%
Yield 2027 *
5.83%
Yield 2028 * 6.32%
1 day+0.12%
1 week-0.27%
Current month+0.12%
1 month-0.27%
3 months-0.27%
6 months-8.18%
Current year-25.69%
1 week 26
Extreme 26
26.61
1 month 26
Extreme 26
26.61
Current year 24.21
Extreme 24.21
46.64
1 year 24.21
Extreme 24.21
46.64
3 years 24.21
Extreme 24.21
47.23
5 years 24.21
Extreme 24.21
47.23
10 years 24.21
Extreme 24.21
47.23
Manager TitleAgeSince
Chief Executive Officer 51 01/07/2025
Director of Finance/CFO - 30/09/2024
Chief Tech/Sci/R&D Officer - 05/08/2024
Director TitleAgeSince
Chairman 66 -
Director/Board Member - 01/07/2019
Director/Board Member 60 01/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.12%-0.27% - - 2.41B
+0.06%-3.11%+22.22%+107.54% 103B
-0.71%-5.40%+53.36%+160.60% 54.89B
-0.38%-2.23%-12.04%+255.41% 21.78B
-0.12%-0.91%-10.25%-7.76% 8.09B
-1.35%-4.37%-37.90%-29.47% 6.96B
+0.59%+0.68%+3.49%+31.73% 6.79B
-0.90%-0.65%-18.17%-26.86% 6.17B
+0.30%+0.06%-4.49%+19.70% 5.08B
-10.00%+1.12%+354.83%+495.04% 5.12B
Average -1.09%+0.00%+39.01%+111.77% 24.17B
Weighted average by Cap. -0.39%-2.68%+29.00%+127.96%

Financials

2027 *2028 *
Net sales 14.03B 10.06B 8.67B 8.21B 7.44B 13.96B 961B 97.52B 37.5B 489B 37.8B 36.97B 1,546B 14.66B 10.51B 9.06B 8.58B 7.77B 14.58B 1,004B 102B 39.17B 511B 39.48B 38.61B 1,614B
Net income 229M 165M 142M 134M 122M 228M 15.72B 1.59B 613M 8B 618M 604M 25.26B 261M 187M 161M 153M 138M 260M 17.89B 1.81B 698M 9.1B 703M 688M 28.76B
Net Debt 1.01B 727M 626M 593M 538M 1.01B 69.45B 7.04B 2.71B 35.33B 2.73B 2.67B 112B 975M 699M 602M 570M 517M 970M 66.78B 6.77B 2.6B 33.98B 2.63B 2.57B 107B
Logo EBOS Group Limited
EBOS Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is also the owner, product marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care, and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, through its own brands, retail healthcare, pharmacy, hospital and logistic services, and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics, Healthcare Logistics Clinical Trials and Clinect.
Employees
5,364
Date Price Change Volume
12/09/26 US$26.03 +0.12% 211
08/09/26 US$26.00 -0.38% 1,455
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
16.28AUD
Average target price
23.56AUD
Spread / Average Target
+44.74%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!